A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age
Clinical trial NCT04837482 · COMPLETED
Trial details
- NCT number
- NCT04837482
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-14
- Primary completion
- 2021-12-07
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.